Results 41 to 50 of about 1,157 (167)

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

open access: yesBMC Pregnancy and Childbirth, 2023
Background Prevention of pregnancy-related alloimmunization and the management of hemolytic disease of the fetus and newborn (HDFN) has significantly improved over the past decades. Considering improvements in HDFN care, the objectives of this systematic
Derek P. de Winter   +3 more
doaj   +1 more source

Value of three hemolysis tests and carboxyhemoglobin in the diagnosis of hemolytic disease of the fetus and newborn

open access: yesZhongguo shuxue zazhi, 2023
Objective To investigate the value of three hemolysis tests and carboxyhemoglobin (COHb) level in the diagnosis of hemolytic disease of the fetus and newborn (HDFN).
Fan ZHAO   +7 more
doaj   +1 more source

Hemolytic Disease of Fetus and Newborn in a Primigravida with Multiple Alloantibodies Involving Anti-Jka and Anti-E: A Case Report

open access: yesOman Medical Journal, 2020
The majority of hemolytic disease of the fetus and newborn (HDFN) reported in the literature is due to ABO and rhesus incompatibility. However, there are also other minor blood groups that have been identified as a cause of HDFN, although the occurrence ...
Salfarina Iberahim   +6 more
doaj   +1 more source

Prevalence of Rhesus & Kell phenotypes among blood donors of Bangladesh

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2022
The Rhesus blood group system is one of the most polymorphic and highly immunogenic systems in humans. Because of its high and strong immunogenicity Rh D antigen testing is mandatory before issuing a compatible blood.
Ayesha Khatun   +4 more
doaj   +1 more source

Investigation of the Prevalence of Non‐ABO Blood Group Antigens in Infertile Women Referred to University Hospitals in Iran: A Cross‐Sectional Study [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Infertility nowadays is considered a disease and a significant global health issue. Despite extensive research, the cause of approximately 15% of infertility cases remains unknown. Additionally, despite the high financial and emotional costs associated with infertility treatment, there is no single universal method that ...
Eftekhar Z   +4 more
europepmc   +2 more sources

Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study. [PDF]

open access: yesTransfusion
BACKGROUND: Neonates with hemolytic disease of the fetus and newborn (HDFN) may require exchange transfusions (ET) for severe hyperbilirubinemia. We evaluated if ET in neonates with HDFN was associated with the maximum maternal titer and antibody ...
de Winter DP   +25 more
europepmc   +3 more sources

The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy.
Mar Bennasar, Antoni Borrell
wiley   +1 more source

Genotypic Frequency of RHC Antigen in Women of Reproductive Age in Pakistan

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To determine the genotypic frequency of RHC antigen in females of reproductive age. Study Design: Cross-sectional study. Place and Duration of Study: Armed Forces Institute of Transfusion (AFIT) and Pak Emirates Military Hospital, (PEMH)
Saima Bashir   +5 more
doaj   +1 more source

Identification and management of fetal anemia due to hemolytic disease

open access: yes, 2022
Introduction Hemolytic disease of the fetus and newborn (HDFN) is a condition caused by maternal alloantibodies against fetal red blood cells (RBCs) that can cause severe morbidity and mortality in the fetus and newborn. Adequate screening programs allow
Oever, R.M. van 't   +6 more
core   +1 more source

Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies

open access: yesTransfusion, EarlyView.
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy